• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大青光眼研究:2. 开角型青光眼进展的危险因素

Canadian Glaucoma Study: 2. risk factors for the progression of open-angle glaucoma.

作者信息

Chauhan Balwantray C, Mikelberg Frederick S, Balaszi A Gordon, LeBlanc Raymond P, Lesk Mark R, Trope Graham E

机构信息

Department of Ophthalmology and Visual Sciences, Dalhousie University, Second Floor, Centennial Bldg, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada B3H 2Y9.

出版信息

Arch Ophthalmol. 2008 Aug;126(8):1030-6. doi: 10.1001/archopht.126.8.1030.

DOI:10.1001/archopht.126.8.1030
PMID:18695095
Abstract

OBJECTIVE

To determine systemic and ocular risk factors for visual field progression in open-angle glaucoma.

METHODS

In the Canadian Glaucoma Study, a multicenter prospective longitudinal study of 258 patients (131 men and 127 women; median age, 65.0 years), baseline systemic measures included assessment of peripheral vasospasm and markers for hematopathology, coagulopathy, and immunopathology. Patients were followed up at 4-month intervals with perimetry, optic disc imaging, and a standardized interventional protocol for intraocular pressure control. Univariate and proportional hazards models were used to identify factors that predicted progression.

MAIN OUTCOME MEASURE

Visual field progression with standard automated perimetry.

RESULTS

Median follow-up was 5.3 years, with 167 patients (64.7%) completing 5 years or more and 67 patients (26.0%) completing 7 years or more. Abnormal baseline anticardiolipin antibody levels (hazard ratio [HR], 3.86; 95% confidence interval [CI], 1.60-9.31), higher baseline age (HR per year, 1.04; 95% CI, 1.01-1.07), female sex (HR, 1.94; 95% CI, 1.09-3.46), and higher mean follow-up intraocular pressure (HR per 1 mm Hg, 1.19; 95% CI, 1.05-1.36) before progression were associated with progression.

CONCLUSIONS

The Canadian Glaucoma Study identified 4 independent predictive factors for glaucomatous field progression. Application to Clinical Practice While confirming the importance of intraocular pressure in glaucoma progression, this study determined other risk factors that merit awareness.

摘要

目的

确定开角型青光眼视野进展的全身和眼部危险因素。

方法

在加拿大青光眼研究中,对258例患者(131例男性和127例女性;中位年龄65.0岁)进行了多中心前瞻性纵向研究,基线全身测量包括外周血管痉挛评估以及血液病理学、凝血病和免疫病理学标志物评估。患者每隔4个月接受一次视野检查、视盘成像以及标准化的眼压控制干预方案随访。采用单变量和比例风险模型来识别预测进展的因素。

主要观察指标

标准自动视野检查的视野进展情况。

结果

中位随访时间为5.3年,167例患者(64.7%)完成了5年或更长时间的随访,67例患者(26.0%)完成了7年或更长时间的随访。进展前基线抗心磷脂抗体水平异常(风险比[HR],3.86;95%置信区间[CI],1.60 - 9.31)、较高的基线年龄(每年HR,1.04;95% CI,1.01 - 1.07)、女性(HR,1.94;95% CI,1.09 - 3.46)以及进展前较高的平均随访眼压(每1 mmHg的HR,1.19;95% CI,1.05 - 1.36)与进展相关。

结论

加拿大青光眼研究确定了4个青光眼视野进展的独立预测因素。应用于临床实践 本研究在确认眼压在青光眼进展中的重要性的同时,还确定了其他值得关注的危险因素。

相似文献

1
Canadian Glaucoma Study: 2. risk factors for the progression of open-angle glaucoma.加拿大青光眼研究:2. 开角型青光眼进展的危险因素
Arch Ophthalmol. 2008 Aug;126(8):1030-6. doi: 10.1001/archopht.126.8.1030.
2
Canadian Glaucoma Study: 1. Study design, baseline characteristics, and preliminary analyses.加拿大青光眼研究:1. 研究设计、基线特征及初步分析。
Can J Ophthalmol. 2006 Oct;41(5):566-75. doi: 10.1139/i06-057.
3
Incidence and rates of visual field progression after longitudinally measured optic disc change in glaucoma.青光眼纵向测量的视盘改变后视野进展的发生率和速率
Ophthalmology. 2009 Nov;116(11):2110-8. doi: 10.1016/j.ophtha.2009.04.031. Epub 2009 Jun 4.
4
Keratometry, optic disc dimensions, and degree and progression of glaucomatous optic nerve damage.角膜曲率测量、视盘尺寸以及青光眼性视神经损伤的程度和进展情况。
J Glaucoma. 2006 Jun;15(3):206-12. doi: 10.1097/01.ijg.0000212209.25642.01.
5
Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.早期显性青光眼试验中眼压波动与青光眼进展情况
Ophthalmology. 2007 Feb;114(2):205-9. doi: 10.1016/j.ophtha.2006.07.060. Epub 2006 Nov 13.
6
Predictive factors for progressive optic nerve damage in various types of chronic open-angle glaucoma.不同类型慢性开角型青光眼中进行性视神经损伤的预测因素。
Am J Ophthalmol. 2005 Jun;139(6):999-1009. doi: 10.1016/j.ajo.2004.12.056.
7
[Risk factors for visual field loss progression in patients with primary open-angle glaucoma in Wenzhou area].[温州地区原发性开角型青光眼患者视野缺损进展的危险因素]
Zhonghua Yan Ke Za Zhi. 2019 Oct 11;55(10):777-784. doi: 10.3760/cma.j.issn.0412-4081.2019.10.009.
8
Beta-Zone parapapillary atrophy and the velocity of glaucoma progression.β 区视盘旁萎缩与青光眼进展速度。
Ophthalmology. 2010 May;117(5):909-15. doi: 10.1016/j.ophtha.2009.10.016. Epub 2010 Feb 4.
9
Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.青光眼进展干预研究中青光眼性视野进展的预测因素。
Ophthalmology. 2004 Sep;111(9):1627-35. doi: 10.1016/j.ophtha.2004.02.017.
10
Silent cerebral infarct and visual field progression in newly diagnosed normal-tension glaucoma: a cohort study.新诊断的正常眼压性青光眼中的无症状脑梗死与视野进展:一项队列研究。
Ophthalmology. 2009 Jul;116(7):1250-6. doi: 10.1016/j.ophtha.2009.02.003. Epub 2009 May 30.

引用本文的文献

1
Maximum Tolerated Medical Therapy for Glaucoma: Fixed-Dose Combinations of Timolol, Dorzolamide, Brimonidine with Latanoprost Versus Timolol, Dorzolamide with Latanoprost.青光眼的最大耐受药物治疗:噻吗洛尔、多佐胺、溴莫尼定与拉坦前列素的固定剂量组合对比噻吗洛尔、多佐胺与拉坦前列素。
Clin Ophthalmol. 2025 Aug 22;19:2913-2925. doi: 10.2147/OPTH.S540312. eCollection 2025.
2
Identification of a Novel Subtype of Ocular Hypertensive Eyes with the Lowest Risk of Progression Under Treatment.识别一种治疗后进展风险最低的新型眼压升高型眼亚型。
Ophthalmol Ther. 2025 Jun 28. doi: 10.1007/s40123-025-01174-3.
3
Two-Year Outcome of Selective Laser Trabeculoplasty for Normal-Tension Glaucoma in Japan: First-Line or Second-Line Selective Laser Trabeculoplasty (FSS) Study.
日本正常眼压性青光眼选择性激光小梁成形术的两年结果:一线或二线选择性激光小梁成形术(FSS)研究
J Clin Med. 2025 May 15;14(10):3459. doi: 10.3390/jcm14103459.
4
Visual Function After Schlemm's Canal-Based MIGS.基于施莱姆管的微创青光眼手术(MIGS)后的视觉功能
J Clin Med. 2025 Apr 7;14(7):2531. doi: 10.3390/jcm14072531.
5
Six-Month Outcomes from a Prospective, Randomized Study of iStent infinite Versus Hydrus in Open-Angle Glaucoma: The INTEGRITY Study.iStent infinite与Hydrus用于开角型青光眼的前瞻性随机研究的六个月结果:INTEGRITY研究
Ophthalmol Ther. 2025 May;14(5):1005-1024. doi: 10.1007/s40123-025-01126-x. Epub 2025 Mar 25.
6
Comparing the Effectiveness of Propensity Score-Matched Ab Interno Trabeculotomy Between Two Types of Trabecular Hooks.比较两种小梁钩在倾向评分匹配的内路小梁切开术中的有效性。
Clin Ophthalmol. 2025 Feb 21;19:663-671. doi: 10.2147/OPTH.S498940. eCollection 2025.
7
One-Year Outcomes of Trabeculotomy with 120°, 180°, or 360° Schlemm's Canal Incision for Primary Open-Angle Glaucoma: A Retrospective Study.原发性开角型青光眼小梁切开术联合120°、180°或360°施莱姆管切开的一年期疗效:一项回顾性研究
J Clin Med. 2024 Dec 16;13(24):7653. doi: 10.3390/jcm13247653.
8
Performance of Polygenic Risk Scores for Primary Open-Angle Glaucoma in Populations of African Descent.非洲裔人群中原发性开角型青光眼多基因风险评分的表现
JAMA Ophthalmol. 2025 Jan 1;143(1):7-14. doi: 10.1001/jamaophthalmol.2024.4784.
9
Early diagnostics and interventional glaucoma.早期诊断与介入性青光眼
Ther Adv Ophthalmol. 2024 Oct 13;16:25158414241287431. doi: 10.1177/25158414241287431. eCollection 2024 Jan-Dec.
10
Applications of optical coherence tomography angiography in glaucoma: current status and future directions.光学相干断层扫描血管造影在青光眼中的应用:现状与未来方向
Front Med (Lausanne). 2024 Sep 19;11:1428850. doi: 10.3389/fmed.2024.1428850. eCollection 2024.